Fulgent Therapeutics Investor
Fulgent Therapeutics, LLC is a pharmaceutical company focusing on developing and commercializing innovative cancer therapeutics.
Funding Status:
IPO
Industry:
Biotechnology, Genetics, Medical, Pharmaceutical, Therapeutics
Estimated Revenue:
$10M to $50M
Headquarters:
Temple City, California, United States
Last Funding Date:
2016-05-24
Last Funding Type:
Venture - Series Unknown
Employee Number:
51-100